- CH₣28.19bn
- CH₣31.34bn
- $10.40bn
Swiss stocks - Factors to watch on May 6
Switzerland's Alcon Q1 adjusted EPS beats estimates; ups FY profit view
Brief: Alcon Q1 Core Operating Margin 21.2%
Swiss stocks - Factors to watch on May 5
Swiss stocks - Factors to watch on April 30
Brief: Alcon Publishes Agenda For 2026 Annual General Meeting
FTC monitoring how drug companies react to patent cliff, official says
Brief: US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon
US FDA declines to approve Aldeyra's eye disorder drug, shares slump (updated)
US FDA declines to approve Aldeyra's drug for eye disorder
Swiss stocks - Factors to watch on March 17
Brief: Alcon And Lensar Agree To Terminate Merger Agreement
Swiss stocks - Factors to watch on February 25
Brief: Alcon AG Reports Q4 2025 Sales Of $2.7 Bln
Daily disposable contact lenses set to power market rebound in 2026
Europe Research Roundup: Aumovio, Pennon Group, Trelleborg
Brief: Alcon Completes $750 Million Share Repurchase Program
DB ups Alcon to 'buy', sees growth from product innovations
Staar Surgical CEO to exit as part of deal with top shareholder